• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性呼吸道乳头状瘤病:一项纵向研究,比较大型儿科人群中与6型和11型人乳头瘤病毒及其他风险因素相关的严重程度。

Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.

作者信息

Wiatrak Brian J, Wiatrak Deborah W, Broker Thomas R, Lewis Linda

机构信息

Department of Pediatric Otolaryngology, Children's Hospital of Alabama, Birmingham, Alabama, USA.

出版信息

Laryngoscope. 2004 Nov;114(11 Pt 2 Suppl 104):1-23. doi: 10.1097/01.mlg.000148224.83491.0f.

DOI:10.1097/01.mlg.000148224.83491.0f
PMID:15514560
Abstract

OBJECTIVES/HYPOTHESIS: A database was developed for prospective, longitudinal study of recurrent respiratory papillomatosis (RRP) in a large population of pediatric patients. Data recorded for each patient included epidemiological factors, human papilloma virus (HPV) type, clinical course, staged severity of disease at each surgical intervention, and frequency of surgical intervention. The study hypothesizes that patients with HPV type 11 (HPV-11) and patients younger than 3 years of age at diagnosis are at risk for more aggressive and extensive disease.

STUDY DESIGN

The 10-year prospective epidemiological study used disease staging for each patient with an original scoring system. Severity scores were updated at each surgical procedure.

METHODS

Parents of children with RRP referred to the authors' hospital completed a detailed epidemiological questionnaire at the initial visit or at the first return visit after the study began. At the first endoscopic debridement after study enrollment, tissue was obtained and submitted for HPV typing using polymerase chain reaction techniques and in situ hybridization. Staging of disease severity was performed in real time at each endoscopic procedure using an RRP scoring system developed by one of the authors (B.J.W.). The frequency of endoscopic operative debridement was recorded for each patient. Information in the database was analyzed to identify statistically significant relationships between extent of disease and/or HPV type, patient age at diagnosis, and selected epidemiological factors.

RESULTS

The study may represent the first longitudinal prospective analysis of a large pediatric RRP population. Fifty-eight of the 73 patients in the study underwent HPV typing. Patients infected with HPV-11 were significantly more likely to have higher severity scores, require more frequent surgical intervention, and require adjuvant therapy to control disease progression. In addition, patients with HPV-11 RRP were significantly more likely to develop tracheal disease, to require tracheotomy, and to develop pulmonary disease. Patients receiving a diagnosis of RRP before 3 years of age had significantly higher severity scores, higher frequencies of surgical intervention, and greater likelihood of requiring adjuvant medical therapy. Patients with Medicaid insurance had significantly higher severity scores and required more frequent surgical debridement. Birth by cesarean section appeared to be a significant risk factor for more severe disease and necessity of more frequent surgical intervention.

CONCLUSION

Statistical analysis of the relationships among epidemiological factors, HPV type, and clinical course revealed that patients with HPV-11 and patients younger than 3 years of age at RRP diagnosis are prone to develop more aggressive disease as represented by higher severity scores at endoscopic debridement, more frequent operative debridement procedures per year, a greater requirement for adjuvant therapy, and greater likelihood of tracheal disease with tracheotomy.

摘要

目的/假设:开发了一个数据库,用于对大量儿科患者的复发性呼吸道乳头状瘤病(RRP)进行前瞻性纵向研究。为每位患者记录的数据包括流行病学因素、人乳头瘤病毒(HPV)类型、临床病程、每次手术干预时疾病的分期严重程度以及手术干预频率。该研究假设,诊断时感染11型HPV(HPV - 11)的患者以及年龄小于3岁的患者患更具侵袭性和广泛性疾病的风险更高。

研究设计

这项为期10年的前瞻性流行病学研究使用原始评分系统对每位患者进行疾病分期。每次手术时更新严重程度评分。

方法

转诊至作者所在医院的RRP患儿的父母在初次就诊时或研究开始后的首次复诊时完成一份详细的流行病学调查问卷。在研究入组后的首次内镜清创术中,获取组织并使用聚合酶链反应技术和原位杂交进行HPV分型。使用作者之一(B.J.W.)开发的RRP评分系统在每次内镜检查时实时进行疾病严重程度分期。记录每位患者内镜手术清创的频率。分析数据库中的信息,以确定疾病程度和/或HPV类型、诊断时的患者年龄以及选定的流行病学因素之间的统计学显著关系。

结果

该研究可能是对大量儿科RRP患者的首次纵向前瞻性分析。研究中的73名患者中有58名接受了HPV分型。感染HPV - 11的患者更有可能具有更高的严重程度评分,需要更频繁的手术干预,并需要辅助治疗来控制疾病进展。此外,HPV - 11 RRP患者更有可能发展为气管疾病,需要气管切开术,并发展为肺部疾病。3岁前被诊断为RRP的患者具有显著更高的严重程度评分、更高的手术干预频率以及更有可能需要辅助药物治疗。接受医疗补助保险的患者具有显著更高的严重程度评分,并且需要更频繁的手术清创。剖宫产分娩似乎是疾病更严重和需要更频繁手术干预的一个重要风险因素。

结论

对流行病学因素、HPV类型和临床病程之间关系的统计分析表明,RRP诊断时感染HPV - 11的患者以及年龄小于3岁的患者更容易发展为更具侵袭性的疾病,表现为内镜清创时更高的严重程度评分、每年更频繁的手术清创程序、对辅助治疗的更大需求以及气管切开术相关气管疾病的更大可能性。

相似文献

1
Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.复发性呼吸道乳头状瘤病:一项纵向研究,比较大型儿科人群中与6型和11型人乳头瘤病毒及其他风险因素相关的严重程度。
Laryngoscope. 2004 Nov;114(11 Pt 2 Suppl 104):1-23. doi: 10.1097/01.mlg.000148224.83491.0f.
2
Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR.使用SYBR Green实时荧光定量PCR技术鉴定青少年复发性呼吸道乳头状瘤病患者中的人乳头瘤病毒DNA
Int J Pediatr Otorhinolaryngol. 2006 Mar;70(3):469-73. doi: 10.1016/j.ijporl.2005.07.018. Epub 2005 Aug 30.
3
Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer.11型人乳头瘤病毒在复发性呼吸道乳头瘤相关癌症中的整合
Laryngoscope. 2004 Nov;114(11):1906-9. doi: 10.1097/01.mlg.0000147918.81733.49.
4
[Clinical and molecular biology studies of respiratory papillomatosis].[呼吸道乳头状瘤病的临床与分子生物学研究]
Laryngorhinootologie. 1998 Mar;77(3):157-64. doi: 10.1055/s-2007-996952.
5
HPV types causing juvenile recurrent laryngeal papillomatosis in South Africa.在南非导致青少年复发性喉乳头状瘤病的人乳头瘤病毒类型。
Int J Pediatr Otorhinolaryngol. 2010 Mar;74(3):255-9. doi: 10.1016/j.ijporl.2009.11.016.
6
[Prevalence of human papilloma virus types and their influence on the course of the disease in children suffering from recurrent respiratory papillomatosis].[复发性呼吸道乳头状瘤病患儿人乳头瘤病毒类型的患病率及其对疾病进程的影响]
Vestn Otorinolaringol. 2004(3):29-33.
7
High incidence of malignant transformation of laryngeal papilloma in Taiwan.台湾喉乳头状瘤恶变的高发生率。
Laryngoscope. 2008 Jan;118(1):50-5. doi: 10.1097/MLG.0b013e318155a288.
8
Children and partners of patients with recurrent respiratory papillomatosis have no evidence of the disease during long-term observation.复发性呼吸道乳头状瘤病患者的儿童及伴侣在长期观察期间未出现该疾病迹象。
Int J Pediatr Otorhinolaryngol. 2006 Dec;70(12):2061-6. doi: 10.1016/j.ijporl.2006.07.018. Epub 2006 Sep 1.
9
E6 and E7 oncogene expression by human papilloma virus (HPV) and the aggressive behavior of recurrent laryngeal papillomatosis (RLP).人乳头瘤病毒(HPV)的E6和E7癌基因表达与复发性喉乳头状瘤病(RLP)的侵袭性行为
Pediatr Dev Pathol. 2008 Mar-Apr;11(2):118-21. doi: 10.2350/06-09-0160.1. Epub 2007 Apr 20.
10
Epidemiology of recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病的流行病学。
APMIS. 2010 Jun;118(6-7):450-4. doi: 10.1111/j.1600-0463.2010.02619.x.

引用本文的文献

1
Chinese guideline for the diagnosis and treatment of juvenile-onset recurrent respiratory papillomatosis (2024).《儿童复发性呼吸道乳头状瘤病诊断与治疗中国专家共识(2024年版)》
World J Otorhinolaryngol Head Neck Surg. 2025 Jan 7;11(3):317-339. doi: 10.1002/wjo2.223. eCollection 2025 Sep.
2
HPV vaccination improves immune response in children with respiratory papillomatosis.人乳头瘤病毒疫苗可改善呼吸道乳头状瘤病患儿的免疫反应。
Sci Rep. 2025 Aug 14;15(1):29885. doi: 10.1038/s41598-025-14787-2.
3
Chinese guideline for the diagnosis and treatment of juvenile-onset recurrent respiratory papillomatosis (2024).
《儿童复发性呼吸道乳头状瘤病诊断与治疗中国专家共识(2024年版)》
Pediatr Investig. 2025 Mar 17;9(1):12-34. doi: 10.1002/ped4.12464. eCollection 2025 Mar.
4
"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis".复发性呼吸道乳头状瘤病的流行病学、临床、经济和人文负担的系统文献综述
Respir Res. 2024 Dec 18;25(1):430. doi: 10.1186/s12931-024-03057-w.
5
Genomic diversity of HPV6 and HPV11 in recurrent respiratory papillomatosis: Association with malignant transformation in the lungs and clinical outcomes.复发性呼吸道乳头状瘤病中HPV6和HPV11的基因组多样性:与肺部恶性转化及临床结局的关联
Tumour Virus Res. 2024 Dec;18:200294. doi: 10.1016/j.tvr.2024.200294. Epub 2024 Oct 29.
6
The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.德国 HPV 疫苗免疫计划对 HPV 相关肛门生殖器疾病的影响:来自法定健康保险索赔数据的回顾性分析。
Arch Gynecol Obstet. 2024 Nov;310(5):2639-2646. doi: 10.1007/s00404-024-07692-y. Epub 2024 Sep 4.
7
Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).联合治疗复发性呼吸道乳头瘤病(RRP)的效果。
Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3693-3700. doi: 10.1007/s00405-024-08653-6. Epub 2024 Apr 18.
8
Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review.复发性呼吸道乳头状瘤病的肺部受累:一项系统评价
Infect Dis Rep. 2024 Feb 28;16(2):200-215. doi: 10.3390/idr16020016.
9
Clinico-pathological Factors in Malignant Transformation of RRP.复发性呼吸道乳头状瘤恶变的临床病理因素
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):596-603. doi: 10.1007/s12070-023-04220-3. Epub 2023 Sep 12.
10
Use of extracorporeal membrane oxygenation during resection of recurrent laryngeal papillomatosis: A case report.体外膜肺氧合在复发性喉乳头状瘤切除术的应用:一例报告。
Medicine (Baltimore). 2023 Jun 2;102(22):e33949. doi: 10.1097/MD.0000000000033949.